Showing results (101-110 of 182) with videos related to

Sort By:
Pageof 19
Statistics in Medicine|September 2, 2008
Statistical epidemic modeling with hospital outbreak dataM Wolkewitz, M Dettenkofer, H Bertz, et al.
The Journal of Hospital Infection|June 25, 2014
National European guidelines for the prevention of Clostridium difficile infection: a systematic qualitative reviewM Martin, W Zingg, E Knoll, et al.
The Journal of Antimicrobial Chemotherapy|February 7, 2001
Efficacy of moxifloxacin, trovafloxacin, clinafloxacin and levofloxacin against intracellular Legionella pneumophilaD Jonas, I Engels, C Friedhoff, et al.
Chemotherapy|January 1, 1984
Penetration of cefotetan into serum, myometrium, endometrium and salpingesH M Just, E E Petersen, M Bassler, et al.
Infection|October 18, 2003
Design of a surveillance system of antibiotic use and bacterial resistance in German intensive care units (SARI)E Meyer, D Jonas, F Schwab, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 1, 1992
Prolongation of hospital stay and extra costs due to ventilator-associated pneumonia in an intensive care unitI Kappstein, G Schulgen, U Beyer, et al.
The Journal of Hospital Infection|September 19, 2006
Stenotrophomonas maltophilia and antibiotic use in German intensive care units: data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in German Intensive Care Units)E Meyer, F Schwab, P Gastmeier, et al.
The Thoracic and Cardiovascular Surgeon|June 1, 1992
Added hospital stay due to wound infections following cardiac surgeryI Kappstein, G Schulgen, G Fraedrich, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|June 19, 2004
[SARI: surveillance of antibiotic use and bacterial resistance in German intensive care units. Correlation between antibiotic use and the emergence of resistance]E Meyer, D Jonas, F Schwab, et al.
Infection|September 1, 1995
Synergy of simultaneous administration of ofloxacin and granulocyte colony-stimulating factor in killing of Escherichia coli by human neutrophilsA Kropec, S W Lemmen, H J Grundmann, et al.
Pageof 19